Hospitalization Risk for Adults with Bipolar I Disorder Treated with Oral Atypical Antipsychotics as Adjunctive Therapy with Mood Stabilizers: A Retrospective Analysis of Medicaid Claims Data.

Niu, Xiaoli; Dennen, Syvart; Dembek, Carole; Laubmeier, Kimberly; Liu, Yanmei; Veeranki, Phani; Tocco, Michael; Williams, G Rhys

Niu, Xiaoli; Dennen, Syvart; Dembek, Carole; Laubmeier, Kimberly; Liu, Yanmei; Veeranki, Phani; Tocco, Michael; Williams, G Rhys.

Afiliação

Niu X; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts.
Dennen S; PRECISIONheor, Los Angeles, California.
Dembek C; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts.
Laubmeier K; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts.
Liu Y; PRECISIONheor, Los Angeles, California.
Veeranki P; PRECISIONheor, Los Angeles, California.
Tocco M; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts.
Williams GR; Sunovion Pharmaceuticals Inc, Marlborough, Massachusetts.

Curr Ther Res Clin Exp ; 94: 100629, 2021.

Article em En | MEDLINE | ID: mdl-34306269

Palavras-chave

Atypical antipsychotics; Bipolar I disorder; Hospitalization; Medicaid; lurasidone

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Tipo de estudo: Etiology_studies / Observational_studies / Risk_factors_studies Idioma: En Ano de publicação: 2021 Tipo de documento: Article

Texto completo

Imprimir

XML

PubMed Links

Buscar no Google